783 related articles for article (PubMed ID: 19317849)
21. Immunohistochemical expression of androgen receptor in salivary gland cancers.
Sygut D; Bień S; Ziółkowska M; Sporny S
Pol J Pathol; 2008; 59(4):205-10. PubMed ID: 19391487
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: possible implications for targeted therapy.
Shang J; Shui Y; Sheng L; Wang K; Hu Q; Wei Q
Oncol Rep; 2008 Feb; 19(2):435-40. PubMed ID: 18202792
[TBL] [Abstract][Full Text] [Related]
23. The alteration of Id-1 and TSP-1 expression in mucoepidermoid carcinoma associated with its clinical features and prognosis.
Yang S; Guo LJ; Tang XF; Tan K; Gong RG; Li A; Yu T; Gao QH; Xuan M; Wen YM; Wang CM; Wang XY
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):29-35. PubMed ID: 19906510
[TBL] [Abstract][Full Text] [Related]
24. [A 20-year retrospective histoclinical analysis of parotid gland tumors in the ENT Department AM in Katowice].
Gierek T; Majzel K; Jura-Szołtys E; Slaska-Kaspera A; Witkowska M; Klimczak-Gołab L
Otolaryngol Pol; 2007; 61(4):399-403. PubMed ID: 18260221
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
[TBL] [Abstract][Full Text] [Related]
26. [Minor salivary gland tumours: a 10-year study].
Targa-Stramandinoli R; Torres-Pereira C; Piazzetta CM; Giovanini AF; Amenábar JM
Acta Otorrinolaringol Esp; 2009; 60(3):199-201. PubMed ID: 19558907
[TBL] [Abstract][Full Text] [Related]
27. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.
Ko YH; Roh JH; Son YI; Chung MK; Jang JY; Byun H; Baek CH; Jeong HS
J Oral Pathol Med; 2010 Apr; 39(4):349-55. PubMed ID: 20040022
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors.
Al-Rawi NH; Omer H; Al Kawas S
J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475
[TBL] [Abstract][Full Text] [Related]
29. [The role of neck dissection in the eradication of salivary carcinomas].
Lin GC
Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 May; 26(3):137-9, 190. PubMed ID: 1652411
[TBL] [Abstract][Full Text] [Related]
30. Epithelial salivary tumors in Sri Lanka: a retrospective study of 713 cases.
Tilakaratne WM; Jayasooriya PR; Tennakoon TM; Saku T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):90-8. PubMed ID: 19403317
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and outcome analysis of submandibular gland cancer: a clinical audit.
Mallik S; Agarwal J; Gupta T; Kane S; Laskar SG; Budrukkar A; Murthy V; Goel V; Jain S
J Oral Maxillofac Surg; 2010 Sep; 68(9):2104-10. PubMed ID: 20538399
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Luukkaa H; Klemi P; Hirsimäki P; Vahlberg T; Kivisaari A; Kähäri VM; Grénman R
Acta Oncol; 2010; 49(1):85-90. PubMed ID: 19929564
[TBL] [Abstract][Full Text] [Related]
33. Salivary gland tumours: a 15-year review at the Dental Centre Lagos University Teaching Hospital.
Ladeinde AL; Adeyemo WL; Ogunlewe MO; Ajayi OF; Omitola OG
Afr J Med Med Sci; 2007 Dec; 36(4):299-304. PubMed ID: 18564644
[TBL] [Abstract][Full Text] [Related]
34. Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma.
Shi J; Wang S; Zhao E; Shi L; Xu X; Fang M
J Oral Pathol Med; 2010 Aug; 39(7):548-51. PubMed ID: 20136697
[TBL] [Abstract][Full Text] [Related]
35. Immunolocalization of DNMT1 and DNMT3a in salivary gland neoplasms.
Cavaliéri Gomes C; da Silveira e Oliveira C; Santos Pimenta LG; De Marco L; Santiago Gomez R
Pathobiology; 2009 May; 76(3):136-40. PubMed ID: 19468253
[TBL] [Abstract][Full Text] [Related]
36. Malignant disease of the minor oral salivary glands.
DelBalso AM
Otolaryngol Clin North Am; 1979 Feb; 12(1):135-40. PubMed ID: 220580
[No Abstract] [Full Text] [Related]
37. [Basal cell adenomas of the salivary glands].
Kozlovskiĭ OM
Arkh Patol; 1975; 37(8):60-4. PubMed ID: 170894
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
39. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
40. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study.
Kernohan NM; Blessing K; King G; Corbett IP; Miller ID
J Pathol; 1991 Jan; 163(1):77-80. PubMed ID: 1672154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
